B-1 lymphocytes increase metastatic behavior of melanoma cells through the extracellular signal-regulated kinase pathway

Cancer Science

Volumn 99, Issue 5, 2008, Pages 920-928

  Pérez, Elizabeth Cristina ^a   Machado Jr , Joel ^a   Aliperti, Fabiana ^a   Freymüller, Edna ^a   Mariano, Mario ^a   Lopes, José Daniel ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2;

ANIMAL CELL; ARTICLE; B 1 LYMPHOCYTE; B LYMPHOCYTE; CANCER CELL CULTURE; CANCER INVASION; CELL INTERACTION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA B16; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; ENZYMOLOGY; METABOLISM; METASTASIS; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; B-LYMPHOCYTES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; MAP KINASE SIGNALING SYSTEM; MELANOMA; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; PHOSPHORYLATION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 43649089168     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00776.x     Document Type: Article

References (54)

1. Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004; 4: 839-49.
2. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001; 411: 375-9.
3. Ronnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 1995; 95: 859-73.
4. Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Cell 2005; 7: 513-20.
5. Pollard SJ, Kemp RV, Crawford M, Duarte-Davidson R, Irwin JG, Yearsley R. Characterizing environmental harm: Developments in an approach to strategic risk assessment and risk management. Risk Anal 2004; 24: 1551-60.
6. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992; 13: 265-70.
7. Condeelis J, Pollard JW. Macrophages. obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124: 263-6.
8. Bottazzi B, Polentarutti N, Acero R et al. Regulation of the macrophage content of neoplasms by chemoattractants. Science 1983; 220: 210-2.
9. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989; 169: 1485-90.
10. + myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J Immunol 2000; 165: 779-85.
11. + cells in the development of antitumor immunity. Cancer Res 2004; 64: 1130-9.
12. + T cell responses by dysregulating antigen-presenting cell maturation. J Immunol 1999; 162: 5728-37.
13. Bronte V, Apolloni E, Cabrelle A et al. Identification of a CD11b(+)/ Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 2000; 96: 3838-46.
14. + myeloid cells. J Immunol 2001; 166: 5398-406.
15. Iacomini J, Imanishi-Kari T. The effect of an immunoglobulin mu transgene on B cell maturation. Eur J Immunol 1992; 22: 745-51.
16. Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol 1993; 11: 501-38.
17. Almeida SR, Aroeira LS, Frymuller E et al. Mouse B-1 cell-derived mononuclear phagocyte, a novel cellular component of acute non-specific inflammatory exudate. Int Immunol 2001; 13: 1193-201.
18. + B lymphocytes to macrophages: Insights from normal biphenotypic B/ macrophage cells. Int Rev Immunol 2001; 20: 137-55.
19. Staquicini FI, Moreira CR, Nascimento FD et al. Enzyme and integrin expression by high and low metastatic melanoma cell lines. Melanoma Res 2003;13: 11-8.
20. Machado J Jr, Fernandez PC, Baumann I, Dobbelaere DA. Characterisation of NF-kappa B complexes in Theileria parva-transformed T cells. Microbes Infect 2000; 2: 1311-20.
21. Abrahao TB, Freymuller E, Mortara RA, Lopes JD, Mariano M. Morphological characterization of mouse B-1 cells. Immunobiology 2003; 208: 401-11.
22. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-85.
23. Gum R, Wang H, Lengyel E, Juarez J, Boyd D. Regulation of 92.kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 1997; 14: 1481-93.
24. McCawley LJ, Li S, Wattenberg EV, Hudson LG. Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J Biol Chem 1999; 274: 4347-53.
25. Zeigler ME, Chi Y, Schmidt T, Varani J. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J Cell Physiol 1999; 180: 271-84.
26. Genersch E, Hayess K, Neuenfeld Y, Haller H. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: Involvement of Ras-dependent and -independent pathways. J Cell Sci 2000; 113: 4319-30.
27. Kukreja P, Abdel-Mageed AB, Mondal D, Liu K, Agrawal KC. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Cancer Res 2005; 65: 9891-8.
28. OíGarra A, Chang R, Go N, Hastings R, Haughton G, Howard M. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 1992; 22: 711-17.
29. Zhou JH, Broussard SR, Strle K et al. IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3′-kinase. J Immunol 2001; 167: 4436-42.
30. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002; 8: 240-6.
31. Lim W, Ma W, Gee K et al. Distinct role of p38 and c-Jun N-terminal kinases in IL-10-dependent and IL-10-independent regulation of the costimulatory molecule B7.2 in lipopolysaccharide-stimulated human monocytic cells. J Immunol 2002; 168: 1759-69.
32. Gee K, Lim W, Ma W et al. Differential regulation of CD44 expression by lipopolysaccharide (LPS) and TNF-alpha in human monocytic cells: distinct involvement of c-Jun N-terminal kinase in LPS-induced CD44 expression. J Immunol 2002; 169: 5660-72.
33. Niemand C, Nimmesgern A, Haan S et al. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J Immunol 2003; 170: 3263-72.
34. Ruiter D, Bogenrieder T, Elder D, Herlyn M. Melanoma-stroma interactions: Structural and functional aspects. Lancet Oncol 2002; 3: 35-43.
35. van Kempen LC, Ruiter DJ, van Muijen GN, Coussens LM. The tumor microenvironment: A critical determinant of neoplastic evolution. Eur J Cell Biol 2003; 82: 539-48.
36. Smalley KS. A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? Int J Cancer 2003; 104: 527-32.
37. Satyamoorthy K, Li G, Gerrero MR et al. Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res 2003; 63: 756-9.
38. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997; 137: 481-92.
39. Simon C, Goepfert H, Boyd D. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92.000 type IV collagenase secretion and in vitro invasion. Cancer Res 1998; 58: 1135-9.
40. Lakka SS, Jasti SL, Kyritsis AP et al. Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades. Clin Exp Metastasis 2000; 18: 245-52.
41. Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 2004; 14: 171-9.
42. Murakami T, Maki W, Cardones AR et al. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 2002; 62: 7328-34.
43. Maroni P, Bendinelli P, Matteucci E, Desiderio MA. HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-kappaB. Carcinogenesis 2007; 28: 267-79.
44. + B-1 cells have signaling properties similar to tolerant B cells. J Biol Chem 2002; 277: 30707-15.
45. Sasagawa S, Ozaki Y, Fujita K, Kuroda S. Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat Cell Biol 2005; 7: 365-73.
46. Balmanno K, Cook SJ. Sustained MAP kinase activation is required for the expression of cyclin D1, 21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 1999:18: 3085-97.
47. Ebisuya M, Kondoh K, Nishida E. The duration, magnitude and compartmentalization of ERK MAP kinase activity: Mechanisms for providing signaling specificity. J Cell Sci 2005; 118: 2997-3002.
48. Tarakhovsky A. Bar Mitzvah for B-1 cells: How will they grow up? J Exp Med 1997; 185: 981-4.
49. Karras JG, Wang Z, Huo L, Howard RG, Frank DA, Rothstein TL. Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J Exp Med 1997; 185: 1035-42.
50. Tanguay D, Pavlovic S, Piatelli MJ, Bartek J, Chiles TC. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors. J Immunol 1999; 163: 3160-8.
51. Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol 2001; 13: 211-17.
52. Wen Z, Zhong Z, Darnell JE. Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82: 251-60.
53. Zhang X, Blenis J, Li HC, Schindler C, Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 1995; 267: 1990-4.
54. Kuroki M, OíFlaherty JT. Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines. Biochem J 1999; 34: 691-6.